Showing 2,161 - 2,180 results of 112,027 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 1.45s Refine Results
  1. 2161
  2. 2162
  3. 2163
  4. 2164
  5. 2165
  6. 2166
  7. 2167

    Steady-state concentration dependence of the effect of nicotine on <i>I</i><sub>KAch_ACH</sub> at -50 mV (above) and -110 mV (below) on a relative scale (currents under nicotine re... by Jiří Šimurda (7486118)

    Published 2019
    “…<p>The shift of the concentration dependence at -110 mV towards inhibition was simulated by a decrease of the activation related parameter <i>h</i><sub>2_1</sub> (from 0.085 to 0.037). …”
  8. 2168
  9. 2169

    Hsa_circ_0017639 regulates cisplatin resistance and tumor growth via acting as a miR-1296-5p molecular sponge and modulating sine oculis homeobox 1 expression in non-small cell lun... by Feiyun Chang (12243382)

    Published 2022
    “…In conclusion, circ_0017639 conferred DDP resistance and promoted tumor growth via elevating SIX1 expression through sequestering miR-1296-5p in NSCLC, providing a new mechanism for understanding the chemoresistance and progression of NSCLC.…”
  10. 2170
  11. 2171
  12. 2172
  13. 2173
  14. 2174
  15. 2175
  16. 2176
  17. 2177
  18. 2178

    Activation of Wnt/β-catenin signaling decreases mRNA expressions of <i>Scx</i>, <i>Mkx</i> and <i>Tnmd</i> in rat TDCs. by Yasuzumi Kishimoto (4282138)

    Published 2017
    “…<p>Relative expressions of <i>Axin2</i>, <i>Scx</i>, <i>Mkx</i>, and <i>Tnmd</i> in TDCs treated with 50 ng/ml Wnt3a with or without 5 μM IWR (an inhibitor of β-catenin) <b>(A)</b>, 0 to 4 μM BIO (an activator of β-catenin) <b>(B)</b>, or 0 to 20 μM IWR <b>(C)</b> for 72 hrs. …”
  19. 2179
  20. 2180

    DataSheet1_Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources.ZIP by Gabriella Gálffy (177759)

    Published 2024
    “…The COVID-19 pandemic resulted in a statistically significant decrease in lung cancer incidence, especially in the 50–59 age group (both sexes).…”